Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.
J Neurooncol. 2009 Aug;94(1):97-101
03 de Octubre de 2009
Recently, there has been greater awareness that combination radiation and temozolomide used to treat glioblastomas may cause increased contrast enhancement on the first post radiation MRI scan. However, this increased enhancement may stabilize or decrease over time and represent pseudo-progression (psPD) rather than true progressive disease. It has never been shown that this phenomenon is greater with combination therapy than radiation alone.
